Streptokinase Market

Streptokinase Market - Global Industry Analysis and Opportunity Assessment 2020–2030

Streptokinase Market Segmented By drug class that is Natural, Synthetic with indication type such as Myocardial Infraction, Arterial Thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis


Streptokinase is an enzyme that is used for breaking the blood clot formed during myocardial infraction, arterial thromboembolism and pulmonary embolism. It is FDA approved and also constitutes WHO’s list of Essential Medicines. Streptokinase is a protein obtained from bacterial source and was first discovered in 1933.

Streptokinase is mostly administered intravenously with side effects like bleeding, allergies, nausea among others. The commonly used thrombolytic agent is innately secreted by numerous strains of pathogens. Since it is of bacterial origin, it is generally given only once after the first attack as later dosage may result in allergic reactions. Streptokinase is an extracellular protein and holds immense clinical importance.

Impact of COVID-19 on the global market of streptokinase can be expected in terms of disruption in supply chain, delay in manufacturing and procurements due to regulatory restrictions and local lockdowns in various countries.

Find Out More about the Report Coverage

Streptokinase Market: Drivers and Restraints

The most significant factor driving the global streptokinase market is growing incidences of cardiovascular diseases in the world. As per WHO data there are around 32.4 million population experiencing myocardial infraction and strokes globally.

The general increase in life style related disorder leads to cardiovascular disorder which in turn would give push to the global streptokinase market. The increase in kidney disorder, hypertension, will also provide momentum to the global streptokinase market. growing geriatric population especially in the Western countries who will be the target population for streptokinase will add to the reasons of growing the global streptokinase market.

Improved technologies for diagnosis along with growing awareness among people to early diagnosis of heart conditions will also contribute in the growth of the global streptokinase market. However, stringent regulatory regimes and competitive pricing in the industry can hinder the growth of the global streptokinase market.

Lack of financial affordability together with general unawareness of populations in the developing countries can also be another reason which can slow the growth of the international streptokinase market.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Streptokinase Market: Segmentation

Based on drug class
  • Natural
  • Synthetic
Based on indication type
  • Myocardial Infraction
  • Arterial Thromboembolism
  • Pulmonary Embolism
  • Deep Vein Thrombosis
  • Others
Based on distribution channel
  • Hospital Pharmacies
  • Online Stores
  • Drug Stores
  • Retail Stores

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Streptokinase Market: Overview

The global market of streptokinase is expected to grow robustly due to increasing incidence of myocardial infraction in which it is primarily used as medication. Based on drug class, synthetic segment of the global streptokinase market can be expected to grow steadily owing to the ease of production of the synthetic product coupled with reduced challenge of pathogenicity of the host.

Based on indication type, myocardial infraction segment looks lucrative in the global streptokinase market as there are growing number of incidence of myocardial infraction internationally. Based on distribution channel, hospital pharmacies can be estimated to be attractive in the global streptokinase market owing to the need to medical supervision to administer the dose of streptokinase.

Explore Persistence Market Research’s expertise in promulgation of the business !

Streptokinase Market: Region-wise Outlook

North America can be expected to hold a major share in the global streptokinase market as approximately 1.5 million of myocardial cases are recorded in the USA. Growing geriatric population of the Europe will result in the steady market share of the global streptokinase market in the European region.

Both South Asia and East Asia can be expected to lead emerging global streptokinase market as there are growing incidence of deep vein thrombosis and pulmonary embolism. Middle East and Africa can also be seen as opportunity markets are mortality due to pulmonary embolism is as high as around 70% in Africa.

Streptokinase Market: Key Players

The key players operating in the global streptokinase market are Dabur, Biocon, Biosena, KeePharma, Wanbang, Zydus, Incepta, Ahaan Healthcare Pvt. Ltd., TTK Healthcare, Aristo Pharmaceuticals Private Limited, Neiss Labs Ltd., LGM Pharma, and others.  

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on: 

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  •  Latin America (Mexico. Brazil)           
  • Europe (Germany, U.K, France, Italy, Spain)       
  •  South Asia (India, ASEAN Countries)
  •  East Asia (Japan, China & South Korea)
  •  Oceania (Australia & New Zealand)
  •  Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint


Endoscopic Spinal Surgery Market

The global endoscopic spinal surgery market was valued at US$ 573.6 Mn in 2020, and is expected to exhibit a CAGR of over 8% through the forecast period (2021 – 2031)..

DNA and RNA Sample Preparation

Global DNA and RNA Sample Preparation Market - check share, size, revenue, valuation, CAGR, regional outlook, key players, competitive landscape, latest trends & forecast.

Automated Endoscope Reprocessor Market

The introduction of automated endoscope reprocessors systems in the market demonstrates a huge success in the endoscope business. Manual endoscope cleaning procedures are often tedious, time-consuming, and inefficient, leading to improper endoscope reprocessing..

Lentiviral Vectors Market

The global lentiviral vectors market was valued at US$ 127.6 Mn in 2021, with a projected CAGR of 11.4% for the next ten years, which indicates highly positive market growth. .

Our Clients

Our Clients